Skip to content
naulon
Not checkedNot checked for notices yet.

Proteome-wide epitope mapping identifies a resource of antibodies for SARS-CoV-2 detection and neutralization

Te Liang, Mengli Cheng, Fei Teng and 7 more

Signal Transduction and Targeted Therapy · 2021

doi:10.1038/s41392-021-00573-9 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Since December 2019, the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a worldwide pandemic. 1 Significant efforts have been made to generate antibodies to help study COVID-19 pathogenesis, perform diagnostic testing, and develop treatment to neutralize SARS-CoV-2 activity. However, the specific sequence of amino acids recognized and bound by an antibody, the “epitope” is unknown for most antibodies. In this study, we developed a high-throughput epitope mapping platform using a peptide-based SARS-CoV-2 proteome microarray. 2 to detect the binding epitopes of 57 commercial antibodies to ORF1ab, nucleocapsid (N), spike (S), envelop (E), membrane (M), ORF3a, ORF6, ORF7a, and ORF8 proteins (Supplementary Table S1 ).

Abstract licence: CC BY-NC-ND

References5

  1. 3.

4 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.